Trastuzumab 600mg/5ml solution for injection vials
NHS hospitals in England used £62,831,307 of indicative cost of Trastuzumab 600mg/5ml solution for injection vials in the 12 months to April 2026, about 0.2% of all hospital medicines spend. That is up 1.7% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Trastuzumab 600mg/5ml solution for injection vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Trastuzumab 600mg/5ml solution for injection vials most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Clatterbridge Cancer Centre Nhs Ft | £4,256,923 |
| The Christie Nhs Foundation Trust | £4,148,147 |
| The Royal Marsden Nhs Foundation Trust | £2,137,628 |
| Sheffield Teaching Hospitals Nhs Trust | £1,537,528 |
| Univ Hpl B/Ham Nhs Foundation Trust | £1,433,641 |
| East And North Hertfordshire Nhs Trust | £1,307,754 |
| Nottingham University Hospitals Trust | £1,251,533 |
| United Lincolnshire Hospitals Nhs Trust | £1,163,534 |
| Univ Hpls Bristol Nhs Foundation Trust | £1,112,202 |
| Royal Devon & Exeter Nhs Foundation Trst | £1,087,758 |
The primary-care picture
Trastuzumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Trastuzumab medicine page.